Colonic smooth muscle motility

Colonic smooth muscle motility is the physiological process of coordinated muscular contractions in the large intestine that facilitates the mixing and propulsion of contents toward the rectum (Source: StatPearls, Physiology, Colon Motility, 2023). This process is regulated by the enteric nervous system (ENS), interstitial cells of Cajal (ICC), and extrinsic autonomic innervation, involving a variety of neurotransmitters such as acetylcholine and serotonin (Source: Journal of Neurogastroenterology and Motility, 2011). Because it is a complex physiological function rather than a single protein or gene product, it is not considered a discrete molecular drug target. Therapeutic agents modulate this motility by interacting with specific receptors like the 5-HT4 serotonin receptor (e.g., Prucalopride) or the mu-opioid receptor (e.g., Loperamide) (Source: American Journal of Gastroenterology, 2014). Disorders of colonic motility include irritable bowel syndrome (IBS), chronic idiopathic constipation, and intestinal pseudo-obstruction, which significantly impact patient quality of life. Monitoring efficacy in clinical settings often involves measuring colonic transit time or using the Bristol Stool Scale (Source: Mayo Clinic Proceedings, 2019). Safety concerns for drugs affecting this process include diarrhea, abdominal cramping, and potential electrolyte imbalances. Understanding the underlying molecular drivers of motility is crucial for developing targeted therapies for functional gastrointestinal disorders.

Other names

Colonic peristalsisColonic motor activityLarge intestinal motilityColonic transit

Modulation of colonic motility occurs through the activation or inhibition of specific molecular targets such as 5-HT4 receptors, mu-opioid receptors, muscarinic M3 receptors, and guanylate cyclase-C, which alter smooth muscle contractility and fluid secretion.